New-generation mechanical circulatory support during high-risk PCI: a cross-sectional analysis.

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Medical Devices

Background:

• High-risk percutaneous coronary intervention (PCI) poses significant procedural risks.
• New-generation mechanical circulatory support (MCS) devices offer potential protection during high-risk PCI.
• Limited real-world data exists on the efficacy of these novel MCS devices.

Purpose of the Study:

• To evaluate the effectiveness of new-generation MCS devices in high-risk PCI procedures.
• To compare procedural outcomes and survival rates between MCS-protected and unprotected patients.
• To identify patient subgroups who benefit most from MCS protection.

Main Methods:

• Retrospective analysis of elective high-risk PCI procedures (2011-2018).
• Comparison of 69 MCS-protected patients versus 129 unprotected patients.
• Primary endpoint: composite of procedure-related adverse events; Secondary endpoint: 30-day survival.

Main Results:

• MCS-protected patients had worse baseline left ventricular ejection fraction (LVEF) and higher SYNTAX I scores.
• The primary composite endpoint occurred less frequently in MCS-protected patients (9% vs 20%, p=0.04).
• MCS protection significantly improved 24-hour and 30-day survival rates (100% vs 95% and 98% vs 87%, respectively).

Conclusions:

• New-generation MCS provides better procedural outcomes in high-risk PCI patients.
• Benefit is most pronounced in patients <75 years with LVEF <30% and SYNTAX I >32.
• Larger prospective studies are warranted to confirm these findings.